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2Abstract 
Context: The Melanin Concentrating Hormone Receptor 2 (MCHR2) is a G protein-coupled 
receptor for MCH, a neuropeptide that plays important role in feeding behaviors. MCHR2
maps on chromosome 6q16.3, in a susceptibility locus for childhood obesity. Objective: The 
aim of this study was to investigate the association between MCHR2 variation and human 
obesity. Design: Case control and family-based studies were performed. Participants: 141 
obese children and 24 non-obese adult subjects were sequenced and case-control analyses 
were conducted using 628 severely obese children and 1,401 controls. Results: Eleven Single 
Nucleotide Polymorphisms (SNPs) were identified. We showed nominal association between 
-38,245 ATG A/G SNP (p=0.03, 95%CI=[1.02-1.34], OR=1.17), A76A T/C SNP (p=0.03, 
95%CI=[0.58-0.97], OR=0.75) and childhood obesity. Analysis of 645 trios with childhood 
obesity supported further the A76A T/C association, showing an over-transmission to obese 
children of the at risk T allele (59.0%, p=0.01), especially in children with most severe forms 
of obesity (Zscore of BMI>4) (67.0%, p=0.003). The A76A at risk T allele was also 
associated with overeating during meal (p=0.02) in an additional group of 102 non-obese 
children. None of MCHR2 variants, including the A76A SNP, showed association with adult 
severe obesity, although a trend for association of the T allele of this variant with food 
disinhibition (p=0.06) and higher hunger (p=0.09) was found. This variant was not associated 
with childhood obesity in an independent case-control study including 1,573 subjects 
(p=0.98). Moreover, the A76A SNP did not explain the linkage on the 6q locus. Conclusions: 
Our results altogether suggest that MCHR2 is not a major contributor to polygenic obesity and 
support a modest effect of the A76A SNP on food intake abnormalities in childhood. 
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3If the current epidemic of obesity clearly reflects the environmental and behavior changes 
during the past half-century, genetic background remains important especially in the severe 
forms of obesity, as assessed by ethnic (1), familial (2, 3) or linkage (4) studies. We 
previously identified in the French population, a linkage with childhood obesity on 
chromosome 6q16.3-q24.2 with a Lod score of 4.06 (5). Recently, we reported that variation 
in ENPP1 (Ectonucleotide Pyrophosphatase Phosphodiesterase1) partly contributed to the 
observed linkage (6). Indeed, if we remove the 15 affected sibling pairs from a total of 135 
sibling pairs sharing the ENPP1 at risk haplotype, the Multipoint Lod Score drops from 4.06 
to 1.6 at marker D6S287 and a new maximal score of 2.63 is obtained 16 Mb centromeric to 
the original linkage peak, at marker D6S301 (6).  
MCHR2 is an obvious candidate gene lying under this new peak. The orphan G-coupled 
protein Melanin-Concentrating Hormone Receptor 2 (MCHR2) consists in 340 amino acids 
with a coding sequence distributed over 6 exons (7-9) and showing 38% homology with the 
Melanin-Concentrating Hormone Receptor 1 (MCHR1) (10). MCHR2 displays high-affinity 
binding to MCH (11), which is known to increase food intake and body weight in rodents 
after its central administration (12-14). MCH acts as a functional antagonist of the α-MSH 
(alpha-Melanocyte-Stimulating Hormone), in a complex central network involving the 
melanocortin pathways (15). MCH overexpression leads to obesity and insulin resistance in 
mice (16). In contrast, mice that lack the MCH gene or targeted inactivation of MCH gene in 
neurons cause a phenotype of leanness as a consequence of hypophagia and increased 
metabolic rate (17). Expression of MCHR2 is restricted to several regions in the brain, 
including the arcuate nucleus and the ventral medial nucleus, areas involved in regulation of 
food intake (18). Consistently, these two nucleus have been recently implicated in mediating 
the MCH effect via activation or inhibition of feeding circuits (19).  
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evolution. In contrast to MCHR1, the functional MCHR2 is only expressed in humans, 
primates and carnivores but not in rodents (10). Thus, little is known about the physiological 
role of MCHR2 and human genetics offers unique opportunity to evaluate the contribution of 
this receptor to appetite regulation and associated diseases in humans. This paper investigates 
the implication of variation in MCHR2 in polygenic and monogenic forms of childhood 
obesity and its related quantitative and eating disorders traits.
RESEARCH DESIGN AND METHODS 
Population used for association studies 
Association studies with childhood and adulthood obesity were performed for variants with 
Minor Allele Frequency (MAF) ≥ 5% using a set of 628 unrelated obese children chosen from 
the cohort of 849 obese children available (Male/Female=402/447, age=10.7±3.60 years, 
BMI=28.84±6.56 kg/m2, Z score of BMI=4.16±1.32), 696 unrelated class III obese adults 
(Male/Female=176/520, mean age=45.95±12.06, BMI=47.69±7.22 kg/m2) and 1,401 
nonobese normoglycemic adults (Male/Female=564/837, age=41.32±15.07, BMI=22.42±2.31 
kg/m2). The study protocol was approved by all local ethic committees and an informed 
consent was obtained from each subject before participating in the study.
Obese children cohort 
The pool of obese children used for case/control analysis was constituted of a first set of 424 
unrelated obese children collected from 424 pedigrees with at least one obese child at the 
CNRS – UMR8090 Unit in Lille, and at the Jeanne de Flandres Hospital in Lille, a second set 
of 93 unrelated obese children recruited at the Children’s Hospital, Toulouse, a third set of 24 
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fourth set of 87 unrelated children collected from the Trousseau Hospital. We genotyped the 
A76A T/C SNP in 148 additional obese children collected at the CNRS UMR8090 and in 439 
obese children collected at the Saint Vincent de Paul hospital. Children with a BMI greater 
than the 97th percentile for age and sex reported on the tables of Rolland-Cachera et al. (20) 
(French general population) were defined as obese as recommended by the European 
Childhood Obesity Group (ECOG) (21).  
Obese adults cohort 
The class III obese adult subgroup was constituted by 696 class III obese adults collected at 
the Department of Nutrition of the Hôtel Dieu Hospital in Paris or at the CNRS-Institut 
Pasteur Unit in Lille. Class III obesity status was defined as BMI ≥ 40 kg/m2 in adults.  
Control adults cohort 
The same adult control group was used for both association studies in obese children and 
adults as this group had a longer environmental exposure and still remains non obese. This 
group consisted in 1,401 nonobese (BMI < 27 kg/m²) normoglycemic (fasting glycemia < 
5.56 mmol/l) French Caucasian adults pooled from four separate studies; 360 unrelated 
nonobese and nondiabetic subjects were recruited at the CNRS- Institut Pasteur Unit in Lille, 
235 were recruited by the “Fleurbaix-Laventie Ville Santé” study (22), 396 from the 
HAGUENEAU study (23) and 410 from the SUVIMAX study (24). Absence of stratification 
among all the different studied cohorts was verified using 26 neutral polymorphic markers 
disseminated across the genome (data not shown). We genotyped the A76A T/C SNP in 986 
additional lean adult subjects (BMI < 27 kg/m²) issued from the SUVIMAX cohort. The 
genetic study was approved by the ethical committee’s of Hôtel Dieu Hospital in Paris and 
Centre Hospitalier Régional Universitaire de Lille. 
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one obese child) and 102 non obese childhood trios (BMI < 97th percentile for gender and 
age) and 158 pedigrees with adulthood obesity including 514 individuals (303 obese, 72 
overweight and 139 lean) for Transmission Disequilibrium Test (TDT) analysis for obesity 
status and eating behavior traits.  
Eating behavior traits 
Food behavior in obese adults was assessed by the TFEQ (Three Factor Eating Questionnaire) 
(25), which evaluates the cognitive restraint of eating, disinhibition, and hunger. Scores for 
the TFEQ were available for 500 class III obese patients with familial history of obesity. 
Because the TFEQ is not a validated questionnaire in children, food intake behavior in 102 
young non obese children (46 girls and 56 boys; BMI < 97th percentile for gender and age) 
was assessed by an in-house questionnaire administrated by a trained physician. Seven 
questions were asked. Two questions were related to food intake behavior during a meal 
(presence or absence of hyperphagia and rapidity of food ingestion) and between meals 
(presence or absence of snacking).  
Sequencing and genotyping 
The screening of the MCHR2 gene was done using overlapping PCR fragments that cover all 
exons of the MCHR2 gene, exon/intron junctions, and a part of the putative promoter and the 
3’UTR (UnTranslated Region). Primer details and PCR optimization conditions are available 
from the authors. PCR amplifications were inspected for single bands of expected sizes on 
agarose gels before purification with Montage PCR384 Multiscreen® S384PCR (Millipore). 
Sequencing was performed using the automated ABI Prism 3730 DNA sequencer in 
combination with the Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied 
Biosystems) and purification Sequencing reaction with MultiScreen® SEQ384 filter plates 
(Millipore). 
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extracted from a whole-genome association search performed in 325 obese children and 425 
control subjects (unpublished results), using DNA pooling strategy, as detailed elsewhere 
(26). Genotyping was performed by labeling genomic DNA and hybridizing it to Illumina 
Infinium Human1 and Hap300 BeadArrays, which interrogated 109,365 and 317,503 SNPs, 
respectively. The nine SNPs were in Hardy-Weinberg equilibrium (p>0.01) in both case and 
control subjects. 
The four SNPs with a MAF of >5% were then genotyped in all case and control groups using 
direct sequencing for -38,245 ATG A/G and -38,244 ATG T/C and Light-Cycler/Typer 
technology (Roche) for -26,780 ATG C/T  and A76A T/C. Genotyping error rates calculated 
from duplicate genotypes of 250 individuals were 0% for -38,245 ATG A/G, -26,780 ATG 
C/T, A76A T/C, and 0.9 % for -38,244 ATG T/C. No recurrent mendelian inconsistencies 
were detected in the 608 pedigrees for the two analyzed SNPs (-38,245 ATG A/G, A76A T/C) 
using the PEDCHECK 1.1 program. 
Statistical analysis 
Tests for deviation from Hardy-Weinberg Equilibrium (HWE) and for association were 
performed with the De Finetti program (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl). All SNPs were 
in HWE. We compared all cases against all control individuals as well as class III obese 
adults and obese children separately against the control group. These analyses were done by 
comparing allelic frequencies of the SNPs between cases and controls. Analysis of variance 
and T-test were performed for the studying of quantitative traits in obese and control adults. 
Haplotype frequencies were determined and were compared between groups with the 
UNPHASED software http://www.mrc-bsu.cam.ac.uk/personal/frank/. Familial analysis on 
binary and quantitative traits were performed by the TDTPHASE and QPDTPHASE methods 
implemented in the UNPHASED software. In order to evaluate the effect of the T at risk 
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procedure. SPSS 10.1 software was used for general statistical analysis.
Results 
Screening of the gene 
All exons of the MCHR2 gene, exon/intron junctions, 870 bp of the putative promoter and 
1,095 bp in the 3’UTR were sequenced in 47 obese children from families with evidence for 
linkage of childhood obesity to 6q, 94 obese children with early obesity onset (Z score of 
BMI>4.5, obesity onset before 5 years old), and in 24 non obese normoglycemic adults. We 
identified six SNPs in the promoter region, one non synonymous mutation, two synonymous 
mutations and two SNPs in the 3’ UTR (Figure 1 and 2). Among these SNPs, three were 
frequent (-38,245 ATG A/G, -38,244 ATG T/C and A76A T/C) with minor allele frequencies 
> 5% and Linkage Disequilibrium analysis (LD) showed that these SNPs were in incomplete 
LD (R2 <0.8). Therefore, the three SNPs were selected to be typed in all our samples 
(Appendix Figure 1). 
The eight remaining rare variants including the non synonymous variant R152Q G/A (minor 
allele frequencies < 5%, Table1) were found in both obese and control subjects. These results 
ruled out a potential implication of these variants in monogenic forms of obesity in our studied 
population.
Association studies of frequent SNPs with childhood obesity 
Case/Control analysis was performed for the three SNPs in 2,029 French Caucasians (628 
unrelated obese children and 1,401 normoglycemic non-obese control adults). The A/G -
38,245 G allele and the A76A T allele showed nominal evidence for association with 
childhood obesity (p=0.03, 95% CI= [1.02-1.34], OR=1.17; p=0.03, 95% CI= [0.58-0.97], 
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obesity (p=0.50, Table 2). 
Because our initial screening did not include intronic regions, we analyzed data concerning 
nine additional tagged SNPs covering the MCHR2 introns, that were included in a Whole-
Genome Association scan of childhood obesity performed in a subset of of obese children 
cohort (325 obese children compared to 425 control subjects, unpublished results). The 
location of the intronic SNPs is shown in Figure 1. 
No intronic SNP showed significant (p<0.05) association with childhood obesity, except for 
SNP -26,780 ATG C/T (rs9496085, p=0.035), located in intron 1 of MCHR2. We then 
genotyped rs9496085 in our extended case control set of 2,029 French Caucasians. This SNP 
showed only a modest trend toward association with childhood obesity (p=0.055, 95% CI= 
[0.75-1.00], OR=0.87; Table 2).  
TDT analysis in trios with childhood obesity
TDT analysis of 424 pedigrees with childhood obesity was then performed for the two 
frequent SNPs significantly associated (p<0.05) with childhood obesity in the case control 
design. The SNP -38,245 ATG A/G did not show an allelic transmission distortion in obese 
children (p>0.05, data not shown). However we found evidence of an over-transmission of the 
A76A at risk T allele in obese children (59.0%, p=0.01, 120 transmitted versus 85 non 
transmitted), especially in children with the most severe forms of obesity (Z score of BMI>4) 
(67.0%, p=0.003, 52 transmitted versus 26 non transmitted; Figure 3).  
In an attempt to gain statistical power in our analysis, we then took into account the 
phenotypes and genotypes of three available generations (children, parents and grand parents) 
for the obesity threshold (97th percentile) for gender and age. We analyzed together the over-
transmission of the at risk allele from the heterozygous grand parents to the obese parents and 
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the over-transmission of the at risk allele from the heterozygous parents to the obese children. 
An over-transmission of the “at risk allele” to obese offspring’s was found (61.0%, p=0.002,). 
To investigate if the A76A variant could affect primarily eating behaviors and thus induce 
obesity, we restricted the TDT analysis of eating behavior phenotypes to a subgroup of 102 
non-obese children , given that the T allele was over-transmitted to obese children. These 
non-obese children were issued from the initial 424 pedigrees with childhood obesity and 
showed no distortion of segregation for the T allele (53.8%, p=0.69). Interestingly, the 
analysis of non-obese children with overeating during meal showed a systematic transmission 
of the T allele to these subjects (100%, p=0.004, 6 transmitted versus 0 non transmitted). 
Accordingly, 25% of the TT genotype carriers of the A76A variant showed overeating during 
meal, whereas none of the TC and CC genotype carriers harbored this disorder (p=0.02).
Association studies with adulthood obesity 
No association with adult class III obesity was found for any of the four SNPs (Table 2). 
However, pooled data from obese children and adults showed nominal evidence of association 
with obesity for the -38,245 A/G SNP (p=0.02, 95% CI=[1.02-1.28], OR=1.15) and a trend 
towards association for the A76A T/C SNP (p=0.07, 95% CI=[0.67-1.02], OR=0.83) (Table 
2). In adults there was also a trend toward association of the T allele of the A76A variant with 
higher hunger (p=0.09) and with disinhibition for food (p=0.06, data not shown).  
Haplotype analysis 
To estimate the potential effect of the combination of the MCHR2 SNPs, we performed 
haplotype analysis in obese subjects and controls using the UNPHASED software. The 
haplotype including the two associated SNPs or the four frequent SNPs did not provide 
stronger evidence for association than SNPs analyzed independently (data not shown).  
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Linkage analysis 
After exclusion of subjects carrying at least one risk haplotype of the ENPP1 gene, we tested 
the contribution of the -38,245 A/G and A76A T/C SNPs to the maximum of the linkage peak 
at marker D6S301 using GIST procedure. Our results did not provide any evidence for 
participation of this SNP to the linkage observed on the 6q locus (dominant model, p=0.16). 
Replication study between A76A T/C and childhood obesity 
In an attempt to replicate the association of the A76A T/C in an independent French cohort, 
we genotyped this polymorphism in two additional sets including 986 lean adult subjects 
issued from the SUVIMAX cohort, and 587 obese children collected at the CNRS UMR8090 
(N=148) and the Saint Vincent de Paul hospital (N=439). We did not replicate the association 
between the A76A T allele and childhood obesity (p=0.98, 95% CI=[0.77-1.29], OR=0.99, 
data not shown). 
Discussion 
This study is the first to investigate a possible role of MCHR2 SNPs in human polygenic 
severe obesity in a large population of French Caucasians. The initial case/control analysis 
gave nominal evidence for association between the two variants -38,245 A/G and A76A T/C 
and childhood obesity but this result does not resist to multiple testing correction. Even if the 
TDT analysis supports the contribution of the A76A T/C SNP to childhood obesity, it is 
noteworthy to indicate that none of these two variants showed association with severe forms 
of obesity in adults. We were not able to replicate the association between A76A T/C SNP 
and childhood obesity in an independent case control design including 1,573 subjects. 
Moreover, our results did not provide any evidence for participation of these variants to the 
linkage observed on the 6q locus. This underlines the need to carry on the search for other 
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genetic variants contributing to the observed linkage with childhood obesity on chromosome 
6q.
Our data suggests that the A76A T/C MCHR2 SNP may mediate modest eating behavior 
disorders in childhood such as overeating during meals. However, this result should be 
interpreted with caution because we used a non-validated in-house questionnaire in children.
We also found a trend for an effect of this SNP on food intake parameters in adults. The 
impact of genetic variants of the MCHR2 gene on food intake, if any, seems to be attenuated 
in adulthood, which could explain the lack of association of the A76A variant in severe adult 
obesity. Similar observations have been found for other key components of the central 
regulation of food intake. Farooqi et al. showed an age-related decrease in hyperphagia in 
obese subjects with MC4R mutations, that seems to occur with adulthood (27).  
The observation that genetic variation in MCHR2 could modulate food intake is consistent 
with the proposed role of MCH/MCH receptor pathway in the literature (11). As MCHR1, 
MCHR2 is specifically activated by nanomolar concentrations of MCH, but signals through 
Gq proteins to induce an increase in intracellular [Ca2+] and inositol phosphate 3 (7, 18). As 
A76A is a synonymous coding variation, it seems unlikely that this variant could act by 
increasing the affinity and the binding of MCHR2 to its ligand and thereby induce an 
enhancement in the orexigenic effect of MCH. A more plausible hypothesis could be that this 
variant confers increased RNA stability to MCHR2, which could affect the MCHR2 receptor 
density and the orexigenic effect of MCH. Several reports have highlighted the significance of 
synonymous mutations that affect mRNA secondary structure, which in some cases induce 
diseases (28, 29). In addition, it remains possible that A76A genetic variant could affect exon 
skipping or disrupt splicing process as previously documented in abundant examples of 
synonymous mutations (30, 31). Finally, we cannot exclude the possibility that this variant is 
in linkage disequilibrium with the true functional variant located elsewhere in the MCHR2
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gene. Unfortunately, this SNP was not genotyped in the Hapmap II avoiding us to study the 
extensive LD with A76A in the 6q16 region. A detailed analysis of linkage disequilibrium in 
the MCHR2 region by sequencing of large size population-based cohorts could be useful. If 
LD analysis and association studies revealed that the A76A variant is itself a primary variant 
determining obesity susceptibility, then functional analysis should be undertaken.
In our study, the eight rare SNPs have been found in both obese and control individuals. This 
lack of implication of rare variants of the MCHR2 gene in monogenic forms of obesity in our 
studied population is consistent with the findings of Bell et al. for the MCHR1 gene (32). A 
previous study performed in the United Kingdom population found two non coding SNPs in 
the MCHR2 gene, which were not analyzed as they were rare (33). Screening of this gene in 
white and African-American individuals identified four non coding SNPs and four coding 
mutations (34) that include the three coding mutations identified in our study. A fourth non 
synonymous mutation R63K was identified and was not detected in our initial sequenced set. 
Functional analysis of MCHR2-carrying each of the non synonymous mutations G152Q or 
R63Q demonstrated that this receptor binds MCH and couples to intracellular signalling 
pathways in a similar way to wild type MCHR2 (34). The absence of functional effect 
particularly of the MCHR2-carrying G152Q mutation is consistent with our findings. This 
SNP was found in obese and control subjects at equal frequencies. 
In conclusion, our results suggest that MCHR2 gene is not a major contributor to polygenic 
and monogenic forms of childhood and adulthood obesity. However, the A76A T/C SNP of 
MCHR2 might have a modest effect on food intake abnormalities. These preliminary results 
need to be confirmed in additional populations.  
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Table 1: Positions, base or amino acid changes, RS number (if known) and frequencies 
of the eleven SNPs identified within the MCHR2 gene in the initial screened set. SNPs 
positions in the first column are indicated in relation to the initiation codon ATG or the stop 
codon TGA (in the UCSC genome browser)  
Table 2: Association (p≤0.05) of genotypes and alleles of MCHR2 gene SNPs with 
obesity. Cases Set 1 = 628 French Caucasian children with BMI > 97th percentile. Cases Set 2 
= 696 obese French Caucasian adults with BMI ≥ 40. Control Set = 1,401 non obese and 
normoglycemic French Caucasian adults. N: number of subjects, OR: Odd Ratio, CI: 95% 
Confidence Interval, HW: Hardy Weinberg. Significant p-values are indicated in bold. 
Figure 1: Location of the 20 SNPs in the MCHR2 gene. Exons one to six are represented in 
grey. The eleven SNPs shown below the figure are those identified after the screening of the 
MCHR2 gene: Three variants -38,245 ATG A/G, -38,244 ATG T/C and A76A T/C had a 
MAF>5% and were studied in case/control analysis. The eight remaining SNPs had a 
MAF<5% and were found in both obese and control subjects ruling out a contribution in 
monogenic form of obesity. The nine additional SNPs shown above the figure are the intronic 
tagged SNPs that were included from the whole genome scan study of childhood obesity to 
cover the MCHR2 genetic variation in introns. 
Figure 2: Schematic representation of the structure of the seven-helix transmembrane 
protein MCHR2. Positions of the three coding variations (two synonymous and one non 
synonymous), identified after the MCHR2 screening, are indicated as grey circles. These three 
mutations were also identified in the study of Hawes et al. (34). The bold circles indicate the 
amino acid delimiting the transmembrane domain from both sides of the protein. The dotted 
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circles indicate the non-synonymous mutation R63K that was found in the study of Hawes et 
al. but was not found through our initial screened set. 
Figure 3: Familial association of the A76A T/C in pedigrees with childhood obesity. TDT 
analysis of 424 pedigrees (645 trios) with childhood obesity showed an over-transmission of 
the A76A at risk T allele in obese children (59.0%, p=0.01) and in children with the more 
severe forms of obesity (Z score of BMI >4) (67.0%, p=0.003).  
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Table 1: Positions, base or amino acid changes, RS number (if known) and frequencies of the eleven 
SNPs identified within the MCHR2 gene in the initial screened set. SNPs positions in the first column 
are indicated in relation to the initiation codon ATG or the stop codon TGA (in the UCSC genome 
browser). 
SNPs Location Nucleotide change rs correspondence Frequency 
-38,672 ATG Promoter T/C - 0.7  
-38,531 ATG Promoter C/T rs 9969034 1.4  
-38,471 ATG Promoter G/A - 0.7  
-38,291 ATG Promoter C/T rs 6570474 1.4  
-38,245 ATG Promoter A/G rs 6925272 41.8  
-38,244 ATG Promoter T/C - 19.4  
A76A    (Synonymous) Exon 3 T/C  - 8.6  
G103G  (Synonymous) Exon 3 G/A  - 0.7  
R152Q  (Non synonymous) Exon 4 G/A  - 1.4  
+57 TGA Exon 6 (3’UTR) T/C rs 4839764 0.7  
+508 TGA 3’UTR T/C - 0.7  
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Table 2 : Association (p≤0.05) of genotypes and alleles of MCHR2 gene SNPs with obesity. Cases Set 
1 = 628 French Caucasian children with BMI > 97th percentile. Cases Set 2 = 696 obese French Caucasian 
adults with BMI ≥ 40. Control Set = 1,401 non obese and normoglycemic French Caucasian adults. N: 
number of subjects, OR: Odd Ratio, CI: 95% Confidence Interval, HW: Hardy Weinberg. Significant p-
values are indicated in bold.  
Cohorts Genotypes (frequency) 
Allele freq. 
OR (p-val.)[CI]
HW 
(p-val.) 
 -38,245 ATG  A/G AA AG GG A G 
Set 1 Obese children (N=606) 229 (0.38) 280 (0.46) 97 (0.16) 0.61 0.39 1.17 (0.03) 0.46 
Control (N=1363) 565 (0.41) 630 (0.46) 168 (0.13) 0.65 0.35 [1.02-1.34] 0.72 
Set 2 Morbidly obese (N=623) 234 (0.38) 302 (0.48) 87 (0.14) 0.62 0.38 1.13 (0.09) 0.51 
Control (N=1363) 565 (0.41) 630 (0.46) 168 (0.13) 0.65 0.35 [0.98-1.29 ] 0.72 
Set 1+2 Obese (N=1229) 463 (0.38) 582 (0.47) 184 (0.15) 0.61 0.39 1.15 (0.02) 0.96 
 Control (N=1363) 565 (0.41) 630 (0.46) 168 (0.13) 0.65 0.35 [ 1.02-1.28] 0.72 
 -38,244 ATG  T/C TT TC CC T C   
Set 1 Obese children (N=591) 323 (0.55)  226(0.38) 42 (0.07) 0.74 0.26 1.06 (0.49) 0.75 
Control (N=1362) 760 (0.56) 518 (0.38) 84 (0.06) 0.75 0.25 [ 0.90-1.23] 0.77 
Set 2 Morbidly obese (N=627) 362 (0.58) 228 (0.36) 37 (0.06) 0.76 0.24 0.92 (0.33) 0.89 
Control (N=1362) 760 (0.56) 518 (0.38) 84 (0.06) 0.75 0.25 [0.79-1.08 ] 0.77 
Set 1+2 Obese (N=1218) 685 (0.56) 454 (0.37) 79 (0.06) 0.75 0.25 1.00 (0.96) 0.76 
 Control (N=1362) 760 (0.56) 518 (0.38) 84 (0.06) 0.75 0.25 [0.88-1.13 ] 0.77 
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-26,780 ATG C/T CC CT TT C T  
Set 1 Obese children (N=587) 263 (0.45) 249 (0.42) 75 (0.13) 0.66 0.34 0.87 (0.055) 0.19 
 Control (N=1401) 559 (0.40) 642 (0.46) 200 (0.14) 0.63 0.37 [0.75-1.00 ] 0.49 
Set 2 Morbidly obese (N=634) 252 (0.40) 297 (0.47) 85 (0.13) 0.63 0.37 0.98 (0.83) 0.93 
Control (N=1401) 559 (0.40) 642 (0.46) 200 (0.14) 0.63 0.37 [0.86-1.13] 0.49 
Set 1+2 Obese (N=1221) 515 (0.42) 546 (0.45) 160 (0.13) 0.65 0.35 0.93 (0.19) 0.42 
Control (N=1401) 559 (0.40) 642 (0.46) 200 (0.14) 0.63 0.37 [ 0.83-1.04] 0.49 
A76A T/C TT TC CC T C  
Set 1 Obese children (N=625) 545 (0.87) 77 (0.13) 3 (-) 0.93 0.07 0.75 (0.03) 0.87 
 Control (N=1365) 1139 (0.83) 215 (0.16) 11 (0.01) 0.91 0.09 [0.58-0.97 ] 0.73 
Set 2 Morbidly obese (N=519) 436 (0.84) 82 (0.16) 1 (-) 0.92 0.08 0.93 (0.56) 0.16 
 Control (N=1365) 1139 (0.83) 215 (0.16) 11 (0.01) 0.91 0.09 [0.71-1.20 ] 0.73 
Set 1+2 Obese (N=1144) 981 (0.86) 159 (0.14) 4 (-) 0.93 0.07 0.83 (0.07) 0.36 
 Control (N=1365) 1139 (0.83) 215 (0.16) 11 (0.01) 0.91 0.09 [0.71-1.20 ] 0.73 
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(p=0.01) (p=0.003)
0.67
0.59
0.41
0.33
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